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To the Editor:
Dysplastic findings in blood cells arise due to any challenge
during the course of normal differentiation and can be
encountered in autoimmune disorders (1–3).
Some myelodysplastic findings closely overlap with
features of cellular senescence, which may be dependent
on or independent of telomeres. The latter case is due to
severe DNA damage, oncogenes, oxidative stress, and
strong mitogenic signals (4).
No hallmark of senescence has been identified yet.
Salient features of senescent cells are: 1) permanent
growth arrest (generally in G1); 2) increased cell size
and polyploidy; 3) expression of senescence-associated
β-galactosidase (SA-β-gal) activity; 4) expression of
p16INK4a in some of them, which causes reorganization
of heterochromatin as punctate highly condensed domains
of facultative heterochromatin [(senescence-associated
heterochromatin foci (SAHF)] that silence critical
proproliferative genes; 5) DNA damage response (DDR),
which initiates and maintains the senescence growth
arrest; and 6) secretion of growth factors, proteases, and
cytokines by senescent cells with persistent DDR signaling
(senescence-associated secretory phenotype) (5).
Alterations in cell cycle and reorganization in the genome is
accompanied by altered cytokinesis, karyokinesis, cellular
scaffolding and alterations in cell morphology, formation
of micronuclei (6) or fragmented nuclei, flattened cell
shape, and intracellular vacuoles (7–9).
Herein, we aimed to investigate the coexistence of
cellular senescence with myelodysplastic findings in
patients with juvenile rheumatoid arthritis (JRA, n = 2),
systemic lupus erythematosus (SLE, n = 1), acute immune
thrombocytopenic purpura (ITP, n = 1) and chronic
ITP (n = 1). SLE and chronic ITP patients were not on
any therapy for at least 45 days; the others were at first
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admission (age: 11.6 ± 4.61 years; 2 females, 3 males;
controls: 13.66 ± 4.16). The leukocytes were prepared and
stained by SA-β-gal (8).
All patients had dysmorphic blood cells on blood
smears (up to 80% vs. 25% in the controls). The leukocytes
of all patients displayed positive SA-β-gal staining (by
33%–57% vs. 0% in the controls) (Figure 1) .
In our patients, we could not test all features of
cellular senescence, but not all senescent cells express all
possible senescence markers (5). In our patients, SA-βgal positivity, increased cell size and increased chromatin
clumping, which mimics nuclear fragmentation (10), and
SAHF are compatible with cellular senescence.
We think that the proinflammatory cytokines and
chemokines in SLE, JRA-PT, and ITP patients (11–13) led
to cellular senescence (14) by keeping the immune system
in a state of chronic low-level activation and giving rise to
immunosenescence through loss of telomeres with each S
phase (5), which was increased by inflammatory mediators
that are secreted by senescent cells themselves (14).
Additionally, destruction of tissue environment and stem
cell niches (14) by inflammatory mediators, proteases,
and immune cells may have exacerbated aging through
hematopoietic stem cell dysfunction, altered mitosis, and
dysmorphism.
Essentially, decline in absolute number of T (CD8+,
CD4+) and B lymphocytes (15) in immunosenescence,
abnormal telomere/telomerase system in ITP (16), and
accelerated loss of T cells in juvenile idiopathic arthritis
(17) were reported.
In conclusion, these results suggest that cellular
senescence plays a role in the pathogenesis of autoimmune
disorders and myelodysplastic features may be a reflection
of cellular senescence. Further studies are needed for
confirmation.
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Figure 1. Dysmorphic hematological features of the peripheral blood smears of patient ASİ with chronic ITP (a–g), patient MEY with
JRA (h–n), and patient TÇ with JRA (o–x).
Neutrophils: Macropolycytes (neutrophil of ≥15 µm) (b, c, h, i), hypersegmentation (c), cytoplasmic vacuoles (a), hypogranulation (d,
o), cytoplasmic protrusions with or without granules (h, k), irregular distribution of granules (a, c, j), abnormal nuclei with nucleic
protrusions (q, r), neutrophils with long chromatin between the nuclei (j, o), pseudo-Pelger–Huet cells (o, p). Lymphocytes: Cytoplasmic
protrusions (e, n, u, v, w). Basophils: Centralization of granules (f), abnormal nuclei and hypogranulation (x). Monocytes: Abnormal
nuclei (g, s, t), cytoplasmic vacuoles (g, s), cytoplasmic protrusion (g). Platelets: Big or giant platelets (l, m). β-Gal staining photographs
of the patients: Patient TÇ with JRA (y), patient MBY with JRA (z), patient KÇ with SLE (aa), patient HA with acute ITP (ab), patient
ASİ with chronic ITP (ac), and control (ad) (100×).
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